InnoTherapy Receives Minister of SMEs and Startups Award

[Asia Economy Reporter Hyungsoo Park] InnoTherapy announced on the 10th that CEO Moonsoo Lee received the Minister of SMEs and Startups Award as a ‘2022 Proud Female Venture Entrepreneur.’

CEO Moonsoo Lee was recognized for contributing to the development of the domestic pharmaceutical and medical device industries by successfully obtaining patents, conducting clinical development, and global product commercialization through the development of new biomaterial substances.

Having founded a one-person female enterprise in 2010, CEO Lee secured the ‘adhesive biomacromolecule’ BiMM library development platform technology with the goal of developing global innovative products based on domestic original technology. The company succeeded in commercializing innovative domestic medical products such as ‘InnoSeal,’ ‘InnoSeal Plus,’ and ‘InnoSeal Plus DL,’ which are absorbable internal hemostatic products utilizing biomimetic new materials.

InnoSeal has established itself as a leading domestic hemostatic product in the vascular intervention field. It entered overseas markets by obtaining the highest grade CE certification in Europe. Using the platform technology, the portfolio is expanding from hemostatic agents and sealants to adeno-associated virus-based gene therapy products.

A company official said, "We commercialized domestic products that can replace overseas products based on domestic original technology," adding, "By entering overseas markets, we have enhanced the market competitiveness of Korean medical devices."

They added, "We will continue to fulfill our social responsibility by developing and commercializing new medical materials for the advancement of the domestic pharmaceutical and medical device industries."

This content was produced with the assistance of AI translation services.